Refine
Has Fulltext
- yes (3)
Is part of the Bibliography
- yes (3)
Year of publication
- 2015 (3) (remove)
Document Type
- Journal article (3)
Language
- English (3)
Keywords
- B cells (1)
- EAE (1)
- FTY720-P (1)
- K+ channel (1)
- K2P channels (1)
- KCNK5 (1)
- K\(_{2P}\)5.1 (1)
- Sphingosine 1-Phosphate (1)
- T lymphocytes (1)
- TASK2 (1)
- Zonula Occludens-1 (1)
- autoimmune neuroinflammation (1)
- biomarker (1)
- blood-brain barrier (1)
- chronic cerebrovascular disease (1)
- domain potassium channels (1)
- endothelial cells (1)
- experimental autoimmune encephalomyelitis (1)
- immune cells (1)
- inflammation (1)
- ion channels (1)
- ischemic stroke (1)
- leukocytes (1)
- lymphocytes (1)
- matrix metalloproteinases (1)
- monocytes (1)
- multiple sclerosis (1)
- multiple-sclerosis (1)
- novo renal transplantation (1)
- ph (1)
- potassium channels (1)
- randomized controlled trial (1)
- rat brain microvascular endothelial cell culture (1)
- regulatory T cells (1)
- relapsing multiple sclerosis (1)
- thromboinflammation (1)
- tight junctions (1)
- up-regulation (1)
- vascular permeability (1)
- volume regulation (1)
Institute
EU-Project number / Contract (GA) number
- 026155 (1)
Breakdown of the blood-brain barrier (BBB) is an early hallmark of multiple sclerosis (MS), a progressive inflammatory disease of the central nervous system. Cell adhesion in the BBB is modulated by sphingosine-1-phosphate (S1P), a signaling protein, via S1P receptors (S1P\(_1\)). Fingolimod phosphate (FTY720-P) a functional S1P\(_1\) antagonist has been shown to improve the relapse rate in relapsing-remitting MS by preventing the egress of lymphocytes from lymph nodes. However, its role in modulating BBB permeabilityin particular, on the tight junction proteins occludin, claudin 5 and ZO-1has not been well elucidated to date. In the present study, FTY720-P did not change the transendothelial electrical resistance in a rat brain microvascular endothelial cell (RBMEC) culture exposed to inflammatory conditions and thus did not decrease endothelial barrier permeability. In contrast, occludin was reduced in RBMEC culture after adding FTY720-P. Additionally, FTY720-P did not alter the amount of endothelial matrix metalloproteinase (MMP)-9 and MMP-2 in RBMEC cultures. Taken together, our observations support the assumption that S1P\(_1\) plays a dual role in vascular permeability, depending on its ligand. Thus, S1P\(_1\) provides a mechanistic basis for FTY720-P-associated disruption of endothelial barrierssuch as the blood-retinal barrierwhich might result in macular edema.